WallStreetZenWallStreetZen

NASDAQ: VYNE
Vyne Therapeutics Inc Stock Ownership - Who owns Vyne Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Vyne Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Tyler ZerondaCHIEF FINANCIAL OFFICER2024-04-0194$3.08
$289.52Sell
David DomzalskiPRESIDENT AND CEO2024-04-011,004$3.08
$3.09kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2024-04-01161$3.08
$495.88Sell
Iain StuartCHIEF SCIENTIFIC OFFICER2024-04-01157$3.08
$483.56Sell
Mutya HarschChief Legal Officer and GC2024-01-02161$2.28
$367.08Sell
David DomzalskiPresident and CEO2024-01-021,004$2.28
$2.29kSell
Iain StuartChief Scientific Officer2024-01-02157$2.28
$357.96Sell
Tyler ZerondaChief Financial Officer2024-01-0293$2.28
$212.04Sell
David DomzalskiPresident and CEO2023-11-302,284$2.81
$6.42kBuy
Patrick G. LeporeDirector2023-11-1513,000$3.91
$50.78kBuy

1 of 2

VYNE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYNE insiders and whales buy or sell their stock.

VYNE Shareholders

What type of owners hold Vyne Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC35.00%4,935,057$11.84MInsider
Albert Cha28.45%4,011,236$9.63MInsider
Vivo Capital Viii LLC28.45%4,011,236$9.63MInsider
Remeditex Ventures LLC19.59%2,761,663$6.63MInsider
Presidio Partners 2007 GP LP18.50%2,608,540$6.26MInsider
Venbio Global Strategic Fund Ii LP10.37%1,461,552$3.51MInsider
Eventide Asset Management LLC9.89%1,394,336$3.35MInstitution
Cormorant Asset Management LP9.89%1,394,336$3.35MInstitution
Merck Co Inc8.82%1,243,168$2.98MInsider
Citadel Advisors LLC8.38%1,181,088$2.83MInstitution

1 of 3

VYNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYNE23.19%76.81%Net BuyingNet Selling
EVGN8.48%0.00%
IPA6.56%0.00%
ACHL53.02%0.00%
NTRB2.49%72.38%
View Top Biotech Stocks

Vyne Therapeutics Stock Ownership FAQ

Who owns Vyne Therapeutics?

Vyne Therapeutics (NASDAQ: VYNE) is owned by 56.03% institutional shareholders, 185.59% Vyne Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Vyne Therapeutics shareholder, owning 4.94M shares representing 35.00% of the company. Perceptive Advisors LLC's Vyne Therapeutics shares are currently valued at $11.35M.

If you're new to stock investing, here's how to buy Vyne Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.